Work

Phase II study of utidelone plus fruquintinib for the treatment of platinum-resistant recurrent ovarian cancer (FRUTD trial).

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5579

Authors: Hao Wen, Zheng Feng, Ruimin Li, Huaying Wang, Xingzhu Ju, Zhong Zheng, Qinhao Guo, Yanping Zhong, Li Tang, Xiaohua Wu

Institutions: Fudan University, Fudan University Shanghai Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162553230

Cites:

Cited by:

Related to: